Skip to main content

and
  1. No Access

    Article

    Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

    The mitogen-activated protein kinase (MAPK) signalling network aberrations in metastatic colorectal cancer (mCRC) generate intrinsic dynamic effects and temporal variations that are crucial but often overlooke...

    Débora Contreras-Toledo, Paula Jiménez-Fonseca in British Journal of Cancer (2024)

  2. Article

    Open Access

    Prospective study of predictors for anxiety, depression, and somatization in a sample of 1807 cancer patients

    In cancer patients, psychological distress, which encompasses anxiety, depression, and somatization, arises from the complex interplay of emotional and behavioral reactions to the diagnosis and treatment, sign...

    Veronica Velasco-Durantez, Patricia Cruz-Castellanos in Scientific Reports (2024)

  3. No Access

    Article

    Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer

    This study investigated the impact of systemic cancer therapy on the quality of life, mental well-being, and life satisfaction of cancer patients.

    Adán Rodríguez-Gonzalez, Alberto Carmona-Bayonas in Clinical and Translational Oncology (2023)

  4. Article

    Open Access

    SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

    Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic...

    Jaume Capdevila Castillón, Teresa Alonso Gordoa in Clinical and Translational Oncology (2023)

  5. Article

    Open Access

    CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

    Promoter hypermethylation of tumour suppressor genes is frequently observed during the malignant transformation of colorectal cancer (CRC). However, whether this epigenetic mechanism is functional in cancer or...

    Juan Ramón Tejedor, Alfonso Peñarroya, Javier Gancedo-Verdejo in Clinical Epigenetics (2023)

  6. Article

    Open Access

    Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer

    Patients with advanced cancer suffer significant decline of their psychological state. A rapid and reliable evaluation of this state is essential to detect and treat it and improve quality of life. The aim was...

    Adán Rodriguez-Gonzalez, Raquel Hernández in Health and Quality of Life Outcomes (2023)

  7. Article

    Open Access

    Dignity and psychosocial related variables in elderly advanced cancer patients

    Most cancers occur in older individuals, who are more vulnerable due to functional impairment, multiple comorbidities, cognitive impairment, and lack of socio-familial support. These can undermine patients’ se...

    Carla M. Martín-Abreu, Raquel Hernández, Patricia Cruz-Castellanos in BMC Geriatrics (2022)

  8. Article

    Open Access

    Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality

    The purpose of this study was to investigate the sociodemographic factors related to psychological distress, spirituality, and resilience, and to examine the mediating role of spirituality with respect to psyc...

    Luka Mihic-Gongora, Paula Jiménez-Fonseca, Raquel Hernandez in BMC Palliative Care (2022)

  9. Article

    Open Access

    Psychometric properties of the Spanish version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)

    The aim of this study was to analyze the internal structure of the EORTC QLQ-C30, to examine the validity and normative data for cancer patients.

    Caterina Calderon, Pere J. Ferrando, Urbano Lorenzo-Seva in Quality of Life Research (2022)

  10. Article

    Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic

    Cancer patients are at increased risk for psychological difficulties and COVID-19. We sought to analyze anxiety and depression levels during the COVID-19 pandemic and the association between sociodemographic, ...

    Berta Obispo-Portero, Patricia Cruz-Castellanos in Supportive Care in Cancer (2022)

  11. No Access

    Article

    Psychometric properties and factorial analysis of invariance of the Satisfaction with Life Scale (SWLS) in cancer patients

    The purpose of this study was to assess the psychometric properties of the Satisfaction with Life Scale (SWLS), evaluate the measurement invariance with respect to sex, age, and tumor location, as well as anal...

    Urbano Lorenzo-Seva, Caterina Calderon, Pere Joan Ferrando in Quality of Life Research (2019)

  12. Article

    Open Access

    Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study

    Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy and safety in non-selected patients in a real-life...

    Ana Fernández, Mercedes Salgado, Adelaida García, Elvira Buxò, Ruth Vera in BMC Cancer (2018)

  13. No Access

    Chapter

    Breathlessness in Advanced Cancer Patients: Protocols and Recommendations

    Breathlessness and dyspnea are common terms used to describe a conscious, unpleasant, intense, and frightening experience related to shortness of breath. This is a frequent and distressing symptom in cancer pa...

    Manuel Sánchez Cánovas in Mechanical Ventilation in Critically Ill C… (2018)

  14. No Access

    Article

    Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors

    Somatostatin analogues, aiming to control tumor secretion or growth, constitute the most attractive therapeutic option for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NE...

    Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Ana Custodio in Current Oncology Reports (2017)

  15. Article

    Open Access

    Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

    The choice of chemotherapy in HER2-negative gastric cancer is based on centre’s preferences and adverse effects profile. No schedule is currently accepted as standard, nor are there any factors to predict resp...

    Paula Jiménez Fonseca, Alberto Carmona-Bayonas in British Journal of Cancer (2017)

  16. Article

    Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

    Trastuzumab significantly improves overall survival (OS) when added to cisplatin and fluoropyrimidine as a treatment for HER2-positive advanced gastric cancers (AGC). The aim of this study was to evaluate the ...

    Paula Jiménez-Fonseca, Alberto Carmona-Bayonas in Gastric Cancer (2017)

  17. Article

    Open Access

    Living with Cancer: Through the Eyes of the Patient and the Physician

    This article is co-authored by a patient with colon cancer and his treating oncologist, who interact at two different levels: the instrumental and the emotional and affective one. The patient relates in detail...

    José Manuel Vigo, Paula Jiménez Fonseca, Caterina Calderon in Oncology and Therapy (2016)

  18. Article

    Open Access

    A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia

    We sought to develop and externally validate a nomogram and web-based calculator to individually predict the development of serious complications in seemingly stable adult patients with solid tumours and episo...

    Paula Jiménez Fonseca, Alberto Carmona-Bayonas in British Journal of Cancer (2016)

  19. Article

    Open Access

    Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

    Based on the mechanism of action, combining somatostatin analogues (SSAs) with mTOR inhibitors or antiangiogenic agents may provide synergistic effects for the treatment of patients with neuroendocrine tumours...

    Jaume Capdevila, Isabel Sevilla, Vicente Alonso, Luís Antón Aparicio in BMC Cancer (2015)

  20. No Access

    Article

    Origin of renal cell carcinomas

    Cancer is a heritable disorder of somatic cells: environment and heredity are both important in the carcinogenic process. The primal force is the “two hits” of Knudson’s hypothesis, which has proved true for m...

    Manuel Valladares Ayerbes in Clinical and Translational Oncology (2008)